{"database": "lobbying", "table": "lobbying_activities", "rows": [[2141641, "28cda5de-351a-42e6-9636-41c41d190dac", "Q2", "ENLISTED ASSOCIATION OF THE NATIONAL GUARD OF THE UNITED STATES", 46131, "ENLISTED ASSOCIATION OF THE NATIONAL GUARD OF THE UNITED STATES", 2018, "second_quarter", "VET", "FY19 MILCON-VA bills Direct Report Language.\n \n\nRare Cancers. --- The disproportionate impact of rare cancers on veterans, the number of rare cancers affecting veterans that are understudied and misunderstood, and inadequate treatment options for rare cancers are concerning. Therefore, the Department is instructed to provide a report to the Committees within 90 days of enactment of this Act for each of the last five years: the prevalence rate of rare cancers among veterans; the types of treatments being provided to veterans specifically for rare cancers; any studies on rare cancers conducted by the Department; the Department's expenditures on the treatment of rare cancers; the Department's programs dedicated to addressing rare cancers among veterans; and recommendations on ways the Department can enhance rare cancer treatments for veterans.", "Defense, Dept of (DOD),Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)", null, 20000, 0, 0, "2018-07-10T13:27:06.743000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2141641"], "units": {}, "query_ms": 45.961037976667285, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}